Compare $ABVC vs $ATOS | Chartloom

Compare

$ABVC vs $ATOS

ABVC Biopharma Inc · Atossa Therapeutics Inc

ABVC

ABVC Biopharma Inc

ATOS

Atossa Therapeutics Inc

Compare $ABVC vs $ATOS

Comparing ABVC Biopharma Inc and Atossa Therapeutics Inc

ABVCABVC Biopharma Inc

ATOSAtossa Therapeutics Inc

ABVCABVC Biopharma Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-54.3%

52W performance

-69.1%

FCF yield

-10.4%

ATOSAtossa Therapeutics Inc

Market cap

$24M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.2%

52W performance

-85.3%

FCF yield

-147.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABVC

ATOS

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

ATOS

Atossa Therapeutics Inc

Market Cap

ABVC$26M

ATOS$24M

Enterprise Value

ABVC$27M

ATOS$-2M

Price

ABVC$1.00

ATOS$2.44

P/E Ratio

ABVCN/A

ATOSN/A

P/S Ratio

ABVC39.44x

ATOS145.95x

EV/Sales

ABVC40.47x

ATOS-17.14x

EV/EBITDA

ABVC0.00x

ATOS0.00x

P/B Ratio

ABVC3.06x

ATOS0.87x

P/FCF Ratio

ABVCN/A

ATOSN/A

EV/FCF

ABVC-9.95x

ATOS0.05x

PEG Ratio

ABVCN/A

ATOSN/A

Forward P/E (NTM)

ABVCN/A

ATOSN/A

Forward P/S (NTM)

ABVCN/A

ATOSN/A

Revenue (TTM)

ABVC$0

ATOS$0

Revenue Growth (YoY)

ABVC-100.0%

ATOSN/A

Forward Rev Growth

ABVC0.0%

ATOS184.1%

Gross Margin (TTM)

ABVC0.3%

ATOS62.5%

Operating Margin (TTM)

ABVC0.0%

ATOS0.0%

EBITDA Margin (TTM)

ABVC0.0%

ATOS0.0%

Net Margin (TTM)

ABVC0.0%

ATOS0.0%

FCF Margin (TTM)

ABVCN/A

ATOSN/A

Net Income (TTM)

ABVC$-8M

ATOS$-38M

FCF (TTM)

ABVC$-3M

ATOS$-36M

EPS (TTM)

ABVC-$0.30

ATOS-$4.23

ROE (TTM)

ABVC-7147.0%

ATOS-10299.0%

ROA (TTM)

ABVC-3883.0%

ATOS-8578.0%

ROIC (TTM)

ABVC-6509.0%

ATOS-10299.0%

Cash

ABVC$32K

ATOS$26M

Debt

ABVC$859K

ATOS$0

Net Cash/Debt

ABVC$-827K

ATOS$26M

Current Ratio (TTM)

ABVC0.07x

ATOS5.69x

Quick Ratio (TTM)

ABVC0.05x

ATOS4.81x

Debt/Equity (TTM)

ABVC0.08x

ATOS0.00x

Debt/Assets (TTM)

ABVC0.0%

ATOS0.0%

Interest Coverage (TTM)

ABVCN/A

ATOSN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

ATOS0.00x

Beta

ABVC0.50

ATOS1.39

52W Performance

ABVC-69.1%

ATOS-85.3%

YTD Performance

ABVC-54.3%

ATOS-74.2%

% from 52W High

ABVC-70.0%

ATOS-87.4%

% from 52W Low

ABVC40.8%

ATOS43.5%

Asset Turnover (TTM)

ABVC0.06x

ATOS0.01x

FCF Yield (TTM)

ABVC-10.4%

ATOS-147.1%

Earnings Yield (TTM)

ABVC-30.4%

ATOS-155.0%

Dividend Yield (TTM)

ABVCN/A

ATOSN/A

Rule of 40

ABVC-100.0

ATOS0.0

EV/GP/RG

ABVCN/A

ATOSN/A

Ticker research

View ABVC research View ATOS research

Metric	ABVC ABVC Biopharma Inc	ATOS Atossa Therapeutics Inc
Market & Valuation
Market Cap	$26M	$24M
Enterprise Value	$27M	$-2M
Price	$1.00	$2.44
P/E Ratio	N/A	N/A
P/S Ratio	39.44x	145.95x
EV/Sales	40.47x	-17.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.06x	0.87x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.95x	0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	184.1%
Profitability
Gross Margin (TTM)	0.3%	62.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-38M
FCF (TTM)	$-3M	$-36M
EPS (TTM)	-$0.30	-$4.23
ROE (TTM)	-7147.0%	-10299.0%
ROA (TTM)	-3883.0%	-8578.0%
ROIC (TTM)	-6509.0%	-10299.0%
Financial Health
Cash	$32K	$26M
Debt	$859K	$0
Net Cash/Debt	$-827K	$26M
Current Ratio (TTM)	0.07x	5.69x
Quick Ratio (TTM)	0.05x	4.81x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	1.39
52W Performance	-69.1%	-85.3%
YTD Performance	-54.3%	-74.2%
% from 52W High	-70.0%	-87.4%
% from 52W Low	40.8%	43.5%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.01x
FCF Yield (TTM)	-10.4%	-147.1%
Earnings Yield (TTM)	-30.4%	-155.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View ATOS research

Valuation

P/S Ratio

ABVC

39.44x

ATOS

145.95x

EV/FCF

ABVC

-9.95x

ATOS

0.05x

Growth & revenue

Revenue Growth TTM

ABVC

-100.0%

Forward Revenue Growth

ATOS

184.1%

ABVC

0.0%

Profitability & performance

Gross Margin

ATOS

62.5%

ABVC

0.3%

ROE

ABVC

-7147.0%

ATOS

-10299.0%

FCF Yield %

ABVC

-10.4%

ATOS

-147.1%

52-Week Performance

ABVC

-69.1%

ATOS

-85.3%

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

ATOS

Atossa Therapeutics Inc

Market Cap

ABVC$26M

ATOS$24M

Enterprise Value

ABVC$27M

ATOS$-2M

Price

ABVC$1.00

ATOS$2.44

P/E Ratio

ABVCN/A

ATOSN/A

P/S Ratio

ABVC39.44x

ATOS145.95x

EV/Sales

ABVC40.47x

ATOS-17.14x

EV/EBITDA

ABVC0.00x

ATOS0.00x

P/B Ratio

ABVC3.06x

ATOS0.87x

P/FCF Ratio

ABVCN/A

ATOSN/A

EV/FCF

ABVC-9.95x

ATOS0.05x

PEG Ratio

ABVCN/A

ATOSN/A

Forward P/E (NTM)

ABVCN/A

ATOSN/A

Forward P/S (NTM)

ABVCN/A

ATOSN/A

Revenue (TTM)

ABVC$0

ATOS$0

Revenue Growth (YoY)

ABVC-100.0%

ATOSN/A

Forward Rev Growth

ABVC0.0%

ATOS184.1%

Gross Margin (TTM)

ABVC0.3%

ATOS62.5%

Operating Margin (TTM)

ABVC0.0%

ATOS0.0%

EBITDA Margin (TTM)

ABVC0.0%

ATOS0.0%

Net Margin (TTM)

ABVC0.0%

ATOS0.0%

FCF Margin (TTM)

ABVCN/A

ATOSN/A

Net Income (TTM)

ABVC$-8M

ATOS$-38M

FCF (TTM)

ABVC$-3M

ATOS$-36M

EPS (TTM)

ABVC-$0.30

ATOS-$4.23

ROE (TTM)

ABVC-7147.0%

ATOS-10299.0%

ROA (TTM)

ABVC-3883.0%

ATOS-8578.0%

ROIC (TTM)

ABVC-6509.0%

ATOS-10299.0%

Cash

ABVC$32K

ATOS$26M

Debt

ABVC$859K

ATOS$0

Net Cash/Debt

ABVC$-827K

ATOS$26M

Current Ratio (TTM)

ABVC0.07x

ATOS5.69x

Quick Ratio (TTM)

ABVC0.05x

ATOS4.81x

Debt/Equity (TTM)

ABVC0.08x

ATOS0.00x

Debt/Assets (TTM)

ABVC0.0%

ATOS0.0%

Interest Coverage (TTM)

ABVCN/A

ATOSN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

ATOS0.00x

Beta

ABVC0.50

ATOS1.39

52W Performance

ABVC-69.1%

ATOS-85.3%

YTD Performance

ABVC-54.3%

ATOS-74.2%

% from 52W High

ABVC-70.0%

ATOS-87.4%

% from 52W Low

ABVC40.8%

ATOS43.5%

Asset Turnover (TTM)

ABVC0.06x

ATOS0.01x

FCF Yield (TTM)

ABVC-10.4%

ATOS-147.1%

Earnings Yield (TTM)

ABVC-30.4%

ATOS-155.0%

Dividend Yield (TTM)

ABVCN/A

ATOSN/A

Rule of 40

ABVC-100.0

ATOS0.0

EV/GP/RG

ABVCN/A

ATOSN/A

Ticker research

View ABVC research View ATOS research

Metric	ABVC ABVC Biopharma Inc	ATOS Atossa Therapeutics Inc
Market & Valuation
Market Cap	$26M	$24M
Enterprise Value	$27M	$-2M
Price	$1.00	$2.44
P/E Ratio	N/A	N/A
P/S Ratio	39.44x	145.95x
EV/Sales	40.47x	-17.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.06x	0.87x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.95x	0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	184.1%
Profitability
Gross Margin (TTM)	0.3%	62.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-8M	$-38M
FCF (TTM)	$-3M	$-36M
EPS (TTM)	-$0.30	-$4.23
ROE (TTM)	-7147.0%	-10299.0%
ROA (TTM)	-3883.0%	-8578.0%
ROIC (TTM)	-6509.0%	-10299.0%
Financial Health
Cash	$32K	$26M
Debt	$859K	$0
Net Cash/Debt	$-827K	$26M
Current Ratio (TTM)	0.07x	5.69x
Quick Ratio (TTM)	0.05x	4.81x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	1.39
52W Performance	-69.1%	-85.3%
YTD Performance	-54.3%	-74.2%
% from 52W High	-70.0%	-87.4%
% from 52W Low	40.8%	43.5%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.01x
FCF Yield (TTM)	-10.4%	-147.1%
Earnings Yield (TTM)	-30.4%	-155.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View ATOS research